Search results (24)
« Back to NewsIdentifying early symptoms associated with a diagnosis of childhood, adolescent and young adult cancers
31 July 2024
Researchers from the Nuffield Department of Primary Care Health Sciences have conducted the largest ever study examining symptoms of cancer in children, teenagers and young adults (CTYA) presenting to GPs. The research, published in the British Journal of Cancer, provides crucial new insights that could help improve early diagnosis of cancer in young people.
Study shows disparity in COVID-19 vaccines uptake for immunocompromised individuals, despite evidence of vaccine effectiveness and safety
13 June 2024
A new study by researchers at NDPCHS has shown disparities in vaccine uptake in immunocompromised individuals across ethnic and socioeconomic groups, despite evidence that vaccines are safe and effective for patients with weakened immune systems.
COVID-19 vaccines are safe and effective for people with blood cancer, study finds
15 February 2024
A new study from researchers in our department provides reassuring evidence that COVID-19 vaccines are safe and effective for people with blood cancers, despite their vulnerable immune systems.
New model predicts risk of developing and dying from breast cancer within 10 years to aid personalised screening
24 August 2023
A team of researchers at the University of Oxford, led by the Nuffield Department of Primary Care Health Sciences, have developed a new model that reliably predicts a woman's likelihood of developing and then dying of breast cancer within a decade.
New study offers hope in early detection of oesophageal cancer
15 August 2023
Cancer Digital health & innovation QResearch
Researchers at the Nuffield Department of Primary Care Health Sciences have developed a new tool to predict people’s risks of getting oesophageal cancer in the next ten years.
New Oxford and Nottingham developed tool uses existing health records to predict people’s risk of developing lung cancer within the next 10 years.
6 April 2023
Cancer Digital health & innovation Infection, Respiratory and Acute Care QResearch
A team of researchers from the University of Oxford and the University of Nottingham have developed a new tool, called ‘CanPredict’, able to identify the people most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and, most importantly, lives.
Inequalities in COVID-19 vaccine uptake remain among people with blood cancers
15 February 2023
COVID-19 Cancer Infection, Respiratory and Acute Care QResearch
People with blood cancers are among the most clinically vulnerable individuals to COVID-19 in the UK, and a new analysis of over 12 million patient health records has revealed inequalities in COVID-19 vaccine uptake among this group.
COVID-19 vaccine protects people of all body weights from hospitalisation and death, a study of 9 million adults in England finds
1 July 2022
COVID-19 Health behaviours QResearch
Two doses of the COVID-19 vaccine are effective against severe disease for people who are underweight, overweight, or who have obesity, finds new research published in The Lancet Diabetes and Endocrinology, led by researchers at the University of Oxford.
Time-varying nature of clinical risk factors for pancreatic cancer may aid earlier diagnosis, finds new study
29 June 2022
Body mass index, blood tests, comorbidities and medication use are temporally associated with cancer risk in the three years before a pancreatic cancer diagnosis.
Oxford-led research makes BJGP's top ten most read and published research articles of 2021
15 February 2022
Awards & appointments Digital health & innovation Health Services Research Patient experience QResearch
Four articles, led or co-authored by Oxford researchers in the department, make the BMJ's top 10 list for the most read and published articles of 2021.
COVID-19 infection more likely than vaccines to cause rare cardiovascular complications
16 December 2021
COVID-19 Cardiovascular & metabolic QResearch
Led by the University of Oxford, a team of UK-based researchers have today reported results of the largest ever study to compare the risks of cardiovascular events, such as myocarditis, pericarditis, and cardiac arrhythmia, between different vaccines and COVID-19 infection, and the first to investigate the association between cardiac events and the Oxford-AstraZeneca vaccine.
Department Researchers work highlighted at NCRI festival: Fewer cases of children’s cancer picked up during COVID pandemic
12 November 2021
COVID-19 Cancer Infection, Respiratory and Acute Care QResearch
A study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic. The research, presented at the NCRI Festival, also shows that children who were diagnosed with cancer during the first wave of the pandemic were more likely to have been admitted to intensive care prior to their diagnosis.
Department Researchers work highlighted at NCRI festival: New symptoms identified that could help doctors diagnose pancreatic cancer
8 November 2021
Cancer Infection, Respiratory and Acute Care QResearch
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms – feeling thirsty and having dark urine – in a study presented today (Monday, 8th Jan) at the NCRI Festival.
COVID-19 infection has greater risk of causing very rare neurological events than vaccines
25 October 2021
COVID-19 Digital health & innovation QResearch
Researchers from across the UK, led by the University of Oxford, have today reported on the risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.
Pancreatic cancer early detection funds awarded to department researchers
19 October 2021
Dr Pui San Tan and Professor Julia Hippisley-Cox receive a Research Innovation Award from Pancreatic Cancer UK to develop a risk tool to predict pancreatic cancer in patients with diabetes.
Department led Covid research partnership wins national computing innovation award
11 October 2021
Awards & appointments COVID-19 QResearch
A collaboration which used anonymised GP records to identify 1.5m people most at risk from Covid-19 and prioritise them for vaccination has won the prestigious John Perry Prize for computing innovation in primary care.
Hormone therapy not linked to increased risk of developing dementia
30 September 2021
Policy & health systems QResearch
Use of menopausal hormone therapy (MHT), also known as hormone replacement therapy, HRT) is not associated with an increased risk of developing dementia, regardless of hormone type, dose, or duration, conclude a team of researchers from across the UK.
QCovid highly commended for ‘best use of technology in Patient Safety’ at the 2021 HSJ Patient Safety Awards
23 September 2021
COVID-19 Infection, Respiratory and Acute Care QResearch
Professor Julia Hippisley-Cox and her team have been Highly Commended in the ‘Best use of technology in Patient Safety’ category for the QCovid risk calculator at this year’s Health Service Journal Patient Safety Awards.
Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool
20 September 2021
COVID-19 Infection, Respiratory and Acute Care QResearch
New algorithm predicts those most at risk of serious Covid-19 outcomes from 14 or more days after second vaccination dose, when substantial immunity is expected to have developed Authors hope this new risk tool will allow those who perceive risk to be high to make more informed decisions regarding shielding and potentially inform policy and clinical decisions on booster vaccine doses and monoclonal antibodies
COVID-19 population-based study wins journal award
10 August 2021
COVID-19 Infection, Respiratory and Acute Care QResearch
Research into the risk of hospital admission from COVID-19 is recognised with a "Best Research Paper Award" from the journal Heart.
Blog: Opinions from our research and teaching
Contact our communications team
Opinions expressed are those of the authors and not of Oxford University. Readers' comments will be moderated - see our guidelines for further information.